Evidence map›Paper›PMID 32415179›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2020

Vasopressin and v1br gene expression is increased in the hypothalamic pvn of borderline hypertensive rats.

Bojana Savić, Andrew Martin, Andre Souza Mecawi, Zoran Bukumirić, José Antunes-Rodrigues, David Murphy, Olivera Šarenac, Nina Japundžić-Žigon

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Vasopressin and cardiovascular autonomic adjustment in chronic hypertensive pregnancy.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  3. Article
  4. Paraventricular Nucleus VPhysiology & behavior · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Bojana SavićFaculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, University of Belgrade, Belgrade, Serbia.
Andrew MartinBristol Medical School: Translational Health Sciences, Dorothy Hodgkin Building, University of Bristol, Bristol, BS1 3NY, UK.
Andre Souza MecawiPaulista Medical School, Department of Biophysics, Laboratory of Neuroendocrinology, Federal University of São Paulo, São Paulo, Brazil.
Zoran BukumirićFaculty of Medicine, Institute for Medical Statics and Informatics, University of Belgrade, Belgrade, Serbia.
José Antunes-RodriguesFaculty of Medicine of Ribeirão Preto, Department of Physiology, University of São Paulo, Ribeirão Preto, SP, Brazil.
David MurphyBristol Medical School: Translational Health Sciences, Dorothy Hodgkin Building, University of Bristol, Bristol, BS1 3NY, UK.
Olivera ŠarenacFaculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, University of Belgrade, Belgrade, Serbia.
Nina Japundžić-ŽigonFaculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, University of Belgrade, Belgrade, Serbia. nina.zigon@med.bg.ac.rs.
University of Belgrade · RSUniversity of Bristol · GBUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

Biotechnology and Biological Sciences Research Council BB/J005452/1British Heart Foundation FS/12/5/29339
6 · The paper itself

Abstract

Vasopressin (VP) is a neurohypophyseal peptide best known for its role in maintaining osmotic and cardiovascular homeostasis. The main sources of VP are the supraoptic and paraventricular (PVN) nuclei of the hypothalamus, which coexpress the vasopressin V1a and V1b receptors (V1aR and V1bR). Here, we investigated the level of expression of VP and VP receptors in the PVN of borderline hypertensive rats (BHRs), a key integrative nucleus for neuroendocrine cardiovascular control. Experiments were performed in male BHRs and Wistar rats (WRs) equipped with a radiotelemetry device for continuous hemodynamic recording under baseline conditions and after saline load without or with stress. Autonomic control of the circulation was evaluated by spectral analysis of blood pressure (BP) and heart rate (HR) variability and baroreceptor reflex sensitivity (BRS) using the sequence method. Plasma VP was determined by radioimmunoassay, and VP, V1aR, and V1bR gene expression was determined by RT-qPCR. Under baseline conditions, BHRs had higher BP, lower HR, and stronger BRS than WRs. BP and HR variability was unchanged. In the PVN, overexpression of the VP and V1bR genes was found, and plasma VP was increased. Saline load downregulated V1bR mRNA expression without affecting VP mRNA expression or plasma VP and BP. Adding stress increased BP, HR, and low-frequency sympathetic spectral markers and decreased plasma VP without altering the level of expression of VP and VP receptors in the PVN. It follows that overexpression of VP and V1bR in the PVN is a characteristic trait of BHRs and that sympathetic hyperactivity underlies stress-induced hypertension.

Indexed as

AnimalsBaroreflexCrowdingFemaleHypertensionMaleParaventricular Hypothalamic NucleusRandom AllocationRats, Inbred SHRRats, WistarReceptors, VasopressinStress, PsychologicalVasopressinsReceptors, VasopressinV1a vasopressin receptor, ratVasopressinsBorderline hypertension;Hypothalamic paraventricular nucleusStress;Vasopressin;Vasopressin receptors;

Identifiers

PMID32415179
OpenAlexW3024186483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.